Enliven Therapeutics (ELVN) Stock Chart & Stock Price History $20.27 -0.09 (-0.44%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$20.27 0.00 (0.00%) As of 08/29/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Enliven Therapeutics Stock Price Performance The Enliven Therapeutics (ELVN) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 7.36%, with a year-to-date return of -9.91%. In the past month, the stock has increased 7.76%, reflecting recent market activity. As of the latest close, Enliven Therapeutics traded at $20.27 with a market cap of $1.20 billion and volume of 589,226 shares. Receive ELVN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Enliven Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-0.25%1 Month Performance+7.76%3 Month Performance+13.62%Year-To-Date Performance-9.91%1 Year Performance-7.36% ELVN Stock Chart for Sunday, August, 31, 2025 ELVN Chart by TradingView Enliven Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/29/2025$20.36$20.27-0.44%$20.99$19.92589,226 shs$1.20 billion08/28/2025$20.68$20.36-1.55%$21.14$20.26467,563 shs$1.21 billion08/27/2025$20.32$20.68+1.77%$20.91$20.26487,838 shs$1.23 billion08/26/2025$19.94$20.32+1.91%$20.90$19.96381,374 shs$1.20 billion08/25/2025$20.85$19.94-4.36%$21.00$19.92452,989 shs$1.18 billion08/22/2025$19.84$20.85+5.09%$21.07$19.62830,394 shs$1.24 billion08/21/2025$19.66$19.84+0.92%$20.28$19.30808,904 shs$1.18 billion08/20/2025$19.76$19.66-0.51%$20.03$19.41286,353 shs$1.16 billion08/19/2025$19.75$19.76+0.05%$20.32$19.01223,908 shs$1.17 billion08/18/2025$20.22$19.75-2.32%$21.01$19.75263,243 shs$1.17 billion Get the Latest News and Ratings for ELVN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Enliven Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 08/15/2025$19.77$20.22+2.28%$20.79$19.63346,729 shs$992.20 million08/14/2025$19.99$19.77-1.10%$21.39$19.20319,833 shs$970.11 million08/13/2025$18.89$19.99+5.82%$20.11$18.13361,218 shs$980.89 million08/12/2025$18.11$18.89+4.31%$19.08$18.17289,755 shs$926.93 million08/11/2025$17.69$18.11+2.37%$18.58$17.79227,322 shs$888.66 million08/08/2025$17.90$17.69-1.17%$18.42$17.43574,228 shs$868.05 million08/07/2025$18.84$17.90-4.99%$19.43$17.76345,802 shs$878.34 million08/06/2025$19.22$18.84-1.98%$20.26$18.44390,972 shs$924.48 million08/05/2025$18.74$19.22+2.56%$19.27$18.52516,788 shs$943.13 million08/04/2025$18.73$18.74+0.05%$19.33$18.42273,183 shs$919.55 million08/01/2025$18.81$18.73-0.43%$18.91$18.18490,125 shs$919.06 million07/31/2025$19.32$18.81-2.64%$19.44$18.53409,294 shs$923.01 million07/30/2025$20.07$19.32-3.74%$20.42$19.02304,018 shs$948.03 million Related Companies TG Therapeutics Stock Chart Cytokinetics Stock Chart Ascentage Pharma Group International Stock Chart Krystal Biotech Stock Chart ACADIA Pharmaceuticals Stock Chart ADMA Biologics Stock Chart Telix Pharmaceuticals Stock Chart Vaxcyte Stock Chart PTC Therapeutics Stock Chart Lantheus Stock Chart Receive ELVN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Enliven Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ELVN) was last updated on 8/31/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enliven Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enliven Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
